Healthcare Costs – Medxy AI

Association Between Opioid Use Disorder and Hysterectomy Outcomes: A Comprehensive Clinical Review

By MedXY 08/11/2026

Patients with opioid use disorder (OUD) face higher postoperative complications, longer inpatient stays, and increased costs following hysterectomy. This review synthesizes clinical evidence and explores implications for surgical management and perioperative care.

Gastroenterology General Surgery news

Robotic Versus Laparoscopic Complex Elective Cholecystectomy: Balancing Outcomes and Costs

By MedXY 07/17/2026

Robotic cholecystectomy for complex gallbladder disease reduces postoperative complications and interventions compared to laparoscopic surgery without increasing total costs, suggesting a strategic role for robotic platforms in complex cases.

Critical Care Infectious Diseases news

Clinical Metagenomics in Sepsis: Insights from the DigiSep Randomized Controlled Trial

By MedXY 07/02/2026

The DigiSep trial assessed the impact of metagenomic next-generation sequencing (mNGS) on sepsis outcomes. While primary endpoint improvement was not significant, secondary analyses revealed benefits in mechanical ventilation duration, shock resolution, and quality of life without raising healthcare costs.

Critical Care news Otorhinolaryngology

Open Bedside Surgical Tracheostomy: Evaluating Safety, Outcomes, and Cost Benefits in Critically Ill Adults

By MedXY 06/25/2026

This retrospective study demonstrates that open bedside surgical tracheostomy (OBST) is as safe as operating room tracheostomy (ORST), with similar complication rates and a significant cost reduction, supporting OBST as the preferred approach in critical care settings.

Gastroenterology news Public Health

Opioid Use in Rome IV Irritable Bowel Syndrome: Prevalence and Impact on Quality of Life and Healthcare in the UK

By MedXY 10/09/2025

One in five UK patients with Rome IV IBS regularly use opioids, associated with worse quality of life, more psychological distress, and increased healthcare costs, highlighting a critical need for opioid stewardship in IBS management.